Comprehensive Review of Analytical Approaches for Vinblastine and Vincristine in Cancer Research
Related Experiment Video
Updated: Jan 9, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Hemn A H Barzani1, Rebaz Anwar Omer2, Khalamala Ibrahim Salih Barzani3
1Department of Medical Laboratory Science, College of Health Science, Lebanese French University, Erbil, Iraq.
Abstract:
Vinblastine (VBL) and vincristine (VCR) are vinca alkaloids derived from Catharanthus roseus and are among the most widely used chemotherapeutic agents for treating hematological malignancies and solid tumors. Due to their narrow therapeutic index and complex structural nature, accurate, sensitive, and selective analytical methods are crucial for quantifying these drugs in pharmaceutical formulations, biological matrices, and environmental samples. This review provides a comprehensive overview of reported analytical techniques for VBL and VCR, drawing on major databases such as Scopus, Web of Science, ScienceDirect, PubMed, and Google Scholar, with a focus on the English-language literature. The discussed methods include chromatographic, spectroscopic, electroanalytical, and capillary electrophoretic techniques. High-performance liquid chromatography (HPLC), particularly when coupled with LC-MS/MS, offers exceptional sensitivity, with detection limits as low as 0.025 ng/mL in plasma. Conventional HPLC-UV methods, though less sensitive, remain widely applied in plant extract analysis. Electroanalytical approaches, such as voltammetry using nanomaterial-modified electrodes, offer eco-friendly and cost-effective alternatives with detection limits as low as 0.3 nM. Key analytical considerations include light sensitivity, pH and temperature control, and matrix interferences. Overall, recent methodological advancements enable reliable quantification of VBL and VCR, supporting safer clinical application, toxicity monitoring, and environmental surveillance.
Related Concept Videos
Drugs that Destabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

